Cardiovascular disease and COVID ‐19: Australian and New Zealand consensus statement
Open Access
- 31 July 2020
- journal article
- research article
- Published by Wiley in Medical Journal of Australia
- Vol. 213 (4) , 182-187
Abstract
Introduction The coronavirus 2019 disease (COVID‐19) pandemic is caused by severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2). Pre‐existing cardiovascular disease (CVD) increases the morbi...Keywords
Funding Information
- National Heart Foundation of Australia
This publication has 31 references indexed in Scilit:
- Characteristics of and Important Lessons From the Coronavirus Disease 2019 (COVID-19) Outbreak in ChinaJAMA, 2020
- Staff safety during emergency airway management for COVID-19 in Hong KongThe Lancet Respiratory Medicine, 2020
- Pathological findings of COVID-19 associated with acute respiratory distress syndromeThe Lancet Respiratory Medicine, 2020
- Clinical Characteristics of 138 Hospitalized Patients With 2019 Novel Coronavirus–Infected Pneumonia in Wuhan, ChinaJAMA, 2020
- The presence of a dedicated cardiac surgical intensive care service impacts clinical outcomes in adult cardiac surgery patientsJournal of Cardiac Surgery, 2020
- Clinical features of patients infected with 2019 novel coronavirus in Wuhan, ChinaThe Lancet, 2020
- Prognostic Significance of Elevated Cardiac Troponin-T Levels in Acute Respiratory Distress Syndrome PatientsPLOS ONE, 2012
- Angiotensin-Converting Enzyme 2 (ACE2) Is a Key Modulator of the Renin Angiotensin System in Health and DiseaseInternational Journal of Peptides, 2012
- A crucial role of angiotensin converting enzyme 2 (ACE2) in SARS coronavirus–induced lung injuryNature Medicine, 2005
- Effect of Angiotensin-Converting Enzyme Inhibition and Angiotensin II Receptor Blockers on Cardiac Angiotensin-Converting Enzyme 2Circulation, 2005